| Synthesis and anticancer activity of new dihydropyrimidinone derivatives AS Mostafa, KB Selim European journal of medicinal chemistry 156, 304-315, 2018 | 62 | 2018 |
| Design, synthesis and docking study of novel picolinamide derivatives as anticancer agents and VEGFR-2 inhibitors MA Zeidan, AS Mostafa, RM Gomaa, LA Abou-Zeid, M El-Mesery, ... European journal of medicinal chemistry 168, 315-329, 2019 | 57 | 2019 |
| Design and synthesis of 2‐phenyl benzimidazole derivatives as VEGFR‐2 inhibitors with anti‐breast cancer activity AS Mostafa, RM Gomaa, MA Elmorsy Chemical Biology & Drug Design 93 (4), 454-463, 2019 | 36 | 2019 |
| Identification of new benzimidazole-triazole hybrids as anticancer agents: multi-target recognition, in vitro and in silico studies DIA Othman, A Hamdi, SS Tawfik, AA Elgazar, AS Mostafa Journal of Enzyme Inhibition and Medicinal Chemistry 38 (1), 2166037, 2023 | 27 | 2023 |
| Benzimidazole‐based protein kinase inhibitors: Current perspectives in targeted cancer therapy AM Ali, SS Tawfik, AS Mostafa, MAM Massoud Chemical Biology & Drug Design 100 (5), 656-673, 2022 | 17 | 2022 |
| Design, synthesis, and docking study of new quinoline derivatives as antitumor agents EE Nasr, AS Mostafa, MAA El‐Sayed, MAM Massoud Archiv der Pharmazie 352 (7), 1800355, 2019 | 17 | 2019 |
| New benzimidazole based hybrids: Synthesis, molecular modeling study and anticancer evaluation as TopoII inhibitors NA Nawareg, AS Mostafa, SM El-Messery, MNA Nasr Bioorganic Chemistry 127, 106038, 2022 | 14 | 2022 |
| Design, synthesis and molecular modeling of phenyl dihydropyridazinone derivatives as B-Raf inhibitors with anticancer activity MG Thabit, AS Mostafa, KB Selim, MAA Elsayed, MNA Nasr Bioorganic Chemistry 103, 104148, 2020 | 12 | 2020 |
| Acetylene-free synthesis of 4- vinyloxy pyridine and quinoline A Hamdi, AS Mostafa, CN Watat, MY Laurent, KB Selim, G Dujardin Tetrahedron Letters 57, 5825–5829, 2016 | 10 | 2016 |
| Synthesis and biological evaluation of new 2-(4-fluorophenyl) imidazol-5-ones as anticancer agents YA Abo-Elanwar, AS Mostafa, MAA El-Sayed, MNA Nasr Journal of Applied Pharmaceutical Science 9 (5), 001-011, 2019 | 4 | 2019 |
| Molecular design and synthesis of new 3, 4-dihydropyrimidin-2 (1H)-ones as potential anticancer agents with VEGFR-2 inhibiting activity AS Mostafa, WA Bayoumi, M El-Mesery, A Elgaml Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2019 | 4 | 2019 |
| Design, synthesis, and in silico insights into dual-inhibition of CDK-6/Aurora A kinase by 2-phenylbenzimidazole-based small molecules AM Ali, SS Tawfik, BA Bhongade, MAM Massoud, AS Mostafa Journal of Molecular Structure 1300, 137215, 2024 | 2 | 2024 |
| Thiazole ring-cleavage: Versatile products obtained in the course of synthesis of certain sulfonamide derivatives MA Zeidan, DIA Othman, FE Goda, AS Mostafa Journal of Molecular Structure 1279, 135018, 2023 | 2 | 2023 |
| Insights into modulating the monastrol scaffold: Development of new pyrimidinones as Eg5 inhibitors with anticancer activity MG Thabit, AS Mostafa, KB Selim, MAA Elsayed, MNA Nasr Archiv der Pharmazie 355 (10), 2200029, 2022 | 2 | 2022 |
| Synthesis and In Vitro Activity of Pyrrolo[3,4-d]pyrimidine-2,5-diones as Potential Non-nucleoside HCV Inhibitors AS Mostafa, SAE Bialy, WA Bayoumi, Y Ueda, M Ikeda, N Kato, ... Current Enzyme Inhibition 12 (2), 170-176, 2016 | 2 | 2016 |
| 1, 3-Dipolar cycloaddition of vinyloxy quinolines with α-alkoxy carbonyl aldonitrones or cyclic surrogates: A comparative study for an asymmetric access to trans 4-quinolinoxy … A Hamdi, MY Laurent, A Hémon-Ribaud, AS Mostafa, MAM Massoud, ... Tetrahedron 75 (3), 429-440, 2019 | 1 | 2019 |
| Unveiling new thiazole‐clubbed piperazine derivatives as multitarget anti‐AD: Design, synthesis, and in silico studies EE Nasr, SS Tawfik, MAM Massoud, AS Mostafa Archiv der Pharmazie, e2400044, 2024 | | 2024 |
| Identification of novel sulfathiazole‐triazolo‐chalcone hybrids as VEGFR‐2/EGFR dual inhibitors with antiangiogenic activity and apoptotic induction MA Zeidan, DIA Othman, FE Goda, AS Mostafa Archiv der Pharmazie 357 (3), 2300320, 2024 | | 2024 |
| Benzimidazole based hybrids as privileged candidates for topoII inhibition: Design, synthesis and molecular modeling studies NA Nawareg, AS Mostafa, SM El-Messery, MNA Nasr Journal of Molecular Structure 1298, 137020, 2024 | | 2024 |
| Exploration of antiproliferative potential of modified triazole–benzohydrazone scaffold: Multitarget approach AM Ali, MA Khalaf, BA Bhongade, KB Selim, AS Mostafa Archiv der Pharmazie 357 (2), 2300383, 2024 | | 2024 |
Waleed A. BayoumiDepartment of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Mansoura University在 mans.edu.eg 的电子邮件经过验证
